Sanofi’s new CEO laid out plans Tuesday to shake up one of the Bay State’s biggest drug companies, potentially throwing its 3-year-old diabetes-focused startup Onduo for a loop.
Allison DeAngelis, Biz Journals
Wed, 12/11/2019 - 3:29am